Sinovac Biotech Ltd Sustainability Reports

Sinovac Biotech Ltd. is a biopharmaceutical company that focuses on the research, development, manufacture, and commercialization of human vaccines. Its product portfolio includes vaccines against COVID-19, hepatitis A, enterovirus 71, influenza, and mumps.

Sector: Manufacturing

Country: China

Exchange: Nasdaq

LEI: 529900DOOGH8WKB2WL85

FIGI: BBG001SGZBN3

8 reports from 2011 to 2025

• Sinovac Biotech Ltd 2025 Sustainability Report
• Sinovac Biotech Ltd 2023 Corporate Social Responsibility Report
• Sinovac Biotech Ltd 2022 Corporate Social Responsibility Report
• Sinovac Biotech Ltd 2021 Corporate Social Responsibility Report
• Sinovac Biotech Ltd 2015 Form 20-F